Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
36.33
-2.01 (-5.24%)
Aug 14, 2025, 11:53 AM - Market open

Company Description

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.

The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America.

Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Establishment Labs Holdings Inc.
Establishment Labs Holdings logo
CountryCosta Rica
Founded2004
IPO DateJul 19, 2018
IndustryMedical Devices
SectorHealthcare
Employees1,018
CEOFillipo Caldini

Contact Details

Address:
Building B23 and B25, Coyol Free Zone
Alajuela
Costa Rica
Phone506 2434 2400
Websiteestablishmentlabs.com

Stock Details

Ticker SymbolESTA
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001688757
CUSIP NumberG31249108
ISIN NumberVGG312491084
Employer ID98-1436377
SIC Code3842

Key Executives

NamePosition
Fillipo Peter CaldiniChief Executive Officer and Director
Juan Jose Chacon QuirosFounder and Executive Director
Rajbir Singh DenhoyChief Financial Officer
S. Ross MansbachGeneral Counsel, Chief Compliance Officer and Chief Human Resources Officer
Roberto de MezervilleChief Technology Officer
Ivan BilicSenior Vice President of Commercial Operations - OUS
Jeff EhrhardtSenior Vice President and GM of North America

Latest SEC Filings

DateTypeTitle
Aug 13, 2025SCHEDULE 13G/AFiling
Aug 7, 202510-QQuarterly Report
Aug 7, 20258-KCurrent Report
Jun 12, 20258-KCurrent Report
May 27, 20258-KCurrent Report
May 22, 20258-KCurrent Report
May 21, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
May 13, 2025SCHEDULE 13G/AFiling
May 9, 202510-QQuarterly Report
May 7, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material